BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10856442)

  • 1. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.
    Fujimura M; Hashimoto K; Yamagami K
    Eur J Pharmacol; 2000 Jun; 398(1):1-10. PubMed ID: 10856442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
    Okamura N; Hashimoto K; Kanahara N; Shimizu E; Kumakiri C; Komatsu N; Iyo M
    Eur J Pharmacol; 2003 Feb; 461(2-3):93-8. PubMed ID: 12586203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.
    Hashimoto K; Tomitaka S; Bi Y; Narita N; Minabe Y; Iyo M
    Eur J Neurosci; 1997 Sep; 9(9):1891-901. PubMed ID: 9383212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.
    Fujimura M; Hashimoto K; Yamagami K
    Life Sci; 2000 Oct; 67(23):2865-72. PubMed ID: 11106001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dizocilpine-induced neuropathological changes in rat retrosplenial cortex are reversed by subsequent clozapine treatment.
    Hashimoto K; Fujimura M; Yamagami K
    Life Sci; 2000 Feb; 66(12):1071-8. PubMed ID: 10737357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine.
    Sebens JB; Koch T; Ter Horst GJ; Korf J
    Eur J Pharmacol; 1998 Jul; 353(1):13-21. PubMed ID: 9721035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.
    Roe DL; Bardgett ME; Csernansky CA; Csernansky JG
    Psychopharmacology (Berl); 1998 Jul; 138(2):151-8. PubMed ID: 9718284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atypical antipsychotic drugs vs. haloperidol on expression of heat shock protein in the discrete brain regions of phencyclidine-treated rats.
    Nakahara T; Kuroki T; Hondo H; Tsutsumi T; Fukuda K; Yao H; Uchimura H
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):193-7. PubMed ID: 10581414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
    O'Neill MF; Hicks CA; Shaw G; Parameswaran T; Cardwell GP; O'Neill MJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fos expression induced by olanzapine and risperidone in the central extended amygdala.
    Pinna A; Costa G; Contu L; Morelli M
    Eur J Pharmacol; 2019 Dec; 865():172764. PubMed ID: 31678081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral lesions of the entorhinal cortex differentially modify haloperidol- and olanzapine-induced c-fos mRNA expression in the rat forebrain.
    Seillier A; Coutureau E; Thiriet N; Herbeaux K; Zwiller J; Di Scala G; Will B; Majchrzak M
    Neuropharmacology; 2003 Aug; 45(2):190-200. PubMed ID: 12842125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
    Jardemark KE; Liang X; Arvanov V; Wang RY
    Neuroscience; 2000; 100(1):1-9. PubMed ID: 10996453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
    Deutch AY; Duman RS
    Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain.
    Nakahara T; Kuroki T; Hashimoto K; Hondo H; Tsutsumi T; Motomura K; Ueki H; Hirano M; Uchimura H
    Neuroreport; 2000 Feb; 11(3):551-5. PubMed ID: 10718313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.
    Farber NB; Foster J; Duhan NL; Olney JW
    Schizophr Res; 1996 Jul; 21(1):33-7. PubMed ID: 8998274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.
    Marx CE; VanDoren MJ; Duncan GE; Lieberman JA; Morrow AL
    Neuropsychopharmacology; 2003 Jan; 28(1):1-13. PubMed ID: 12496935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of olanzapine on regional C-Fos expression in rat forebrain.
    Robertson GS; Fibiger HC
    Neuropsychopharmacology; 1996 Feb; 14(2):105-110. PubMed ID: 8822533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A1 receptor agonists block the neuropathological changes in rat retrosplenial cortex after administration of the NMDA receptor antagonist dizocilpine.
    Okamura N; Hashimoto K; Shimizu E; Kumakiri C; Komatsu N; Iyo M
    Neuropsychopharmacology; 2004 Mar; 29(3):544-50. PubMed ID: 14603270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.